Customer Letters

Please note: The following Customer Letters, do not replace the version that you receive from your local Canadian Blood Services site.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, contact your local Hospital Liaison Specialist to determine if the letter is still current.

Displaying 1 - 9 of 9

	Date Sort ascending
CL_2025-09.pdf	2025-03-25	ACTION REQUIRED Implementation Update: CBS Produced Pathogen Reduced Plasma Customer Letter 2025-09 (PDF)
CL_2025-08.pdf	2025-03-05	INFORMATION ONLY New Tamper Indication Device (TID) Trial For Hospitals serviced out of Newfoundland ONLY Customer Letter 2025-08 (PDF)
CL_2025-07.pdf	2025-03-05	INFORMATION ONLY Update for Manual Contingency Process for Labelling Customer Letter 2025-07 (PDF)
CL_2025-06.pdf	2025-03-05	INFORMATION ONLY WinRho SDF 300 mcg Changes to New Filling Line VanRx Customer Letter 2025-06 (PDF) \| Kamada Customer Letter (PDF)
CL_2025-05.pdf	2025-02-27	INFORMATION ONLY Octaplex 500IU/1000IU Changes to Labelling Artwork Customer Letter 2025-05 (PDF) \| Octaplex^® New Design and format for Carton and Leaflet (PDF)
CL_2025-04.pdf	2025-02-04	ACTION REQUIRED Updated Share Splits for Intravenous Immunoglobulins Customer Letter 2025-04 (PDF)
CL_2025-03.pdf	2025-01-31	INFORMATION ONLY Grifols Product Update - Introduction of Gamunex 40g (400mL) vial size in Canada Customer Letter 2025-03 (PDF) \| Grifols Customer Letter (PDF)
CL_2025-02.pdf	2025-01-27	INFORMATION ONLY Discontinuation of Cryosupernatant Plasma (CSP) Customer Letter 2025-02 (PDF)
CL_2025-01.pdf	2025-01-09	INFORMATION ONLY The National Plan for the Management of Shortages of Immunoglobulin (Ig) Products Customer Letter 2025-01 (PDF) \| The National Plan for the Management of Shortages of Immunoglobulin (Ig) Products (PDF)